Shui‐Ping Zhao

6.2k total citations · 1 hit paper
235 papers, 4.3k citations indexed

About

Shui‐Ping Zhao is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shui‐Ping Zhao has authored 235 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Surgery, 76 papers in Cardiology and Cardiovascular Medicine and 61 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shui‐Ping Zhao's work include Lipoproteins and Cardiovascular Health (92 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (50 papers) and Cancer, Lipids, and Metabolism (48 papers). Shui‐Ping Zhao is often cited by papers focused on Lipoproteins and Cardiovascular Health (92 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (50 papers) and Cancer, Lipids, and Metabolism (48 papers). Shui‐Ping Zhao collaborates with scholars based in China, United States and Canada. Shui‐Ping Zhao's co-authors include Daoquan Peng, Ling Liu, Bilian Yu, Zhihong Wu, Mei Gao, Qichang Zhou, Shuhui Wang, Zhenyu Peng, Baimei He and Yuling Li and has published in prestigious journals such as Circulation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Shui‐Ping Zhao

229 papers receiving 4.2k citations

Hit Papers

2023 Chinese guideline for lipid management 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2023 Chinese guideline for lipid management
    2023 81 citations Shui‐Ping Zhao, Daoquan Peng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shui‐Ping Zhao China 35 1.5k 1.2k 1.0k 1.0k 722 235 4.3k
Maria-Corina Șerban Romania 39 1.6k 1.1× 751 0.6× 699 0.7× 760 0.8× 472 0.7× 87 4.5k
Jean Bergeron Canada 33 3.3k 2.1× 1.1k 1.0× 1.8k 1.7× 851 0.8× 746 1.0× 81 6.1k
Junji Kobayashi Japan 35 1.4k 0.9× 1.3k 1.1× 1.6k 1.5× 863 0.9× 595 0.8× 158 3.7k
Olivier Descamps Belgium 28 2.9k 1.9× 1.1k 1.0× 1.5k 1.4× 492 0.5× 344 0.5× 86 4.5k
Kjetil Retterstøl Norway 33 1.6k 1.1× 593 0.5× 946 0.9× 520 0.5× 302 0.4× 189 3.7k
Gen Yoshino Japan 33 1.2k 0.8× 785 0.7× 1.4k 1.4× 643 0.6× 863 1.2× 168 4.2k
Patrick M. Moriarty United States 35 3.1k 2.0× 1.3k 1.1× 1.3k 1.2× 737 0.7× 320 0.4× 109 4.8k
P. Barton Duell United States 33 2.6k 1.7× 745 0.6× 1.0k 1.0× 619 0.6× 338 0.5× 114 4.7k
John R. Burnett Australia 36 2.5k 1.6× 956 0.8× 1.3k 1.2× 1.3k 1.3× 443 0.6× 164 4.6k
Mary J. Malloy United States 45 2.6k 1.7× 1.7k 1.4× 1.9k 1.8× 1.6k 1.6× 608 0.8× 137 7.2k

Countries citing papers authored by Shui‐Ping Zhao

Since Specialization
Citations

This map shows the geographic impact of Shui‐Ping Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shui‐Ping Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shui‐Ping Zhao more than expected).

Fields of papers citing papers by Shui‐Ping Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shui‐Ping Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shui‐Ping Zhao. The network helps show where Shui‐Ping Zhao may publish in the future.

Co-authorship network of co-authors of Shui‐Ping Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Shui‐Ping Zhao. A scholar is included among the top collaborators of Shui‐Ping Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shui‐Ping Zhao. Shui‐Ping Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhao, Zhifeng Cheng, Zhaohui Pei, et al.. (2024). Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia. Nutrition Metabolism and Cardiovascular Diseases. 34(9). 2217–2225. 1 indexed citations
2.
Zheng, Xiaochen, et al.. (2023). Remote sensing monitoring and transport path analysis of an intense dust weather in northern China in 2021. National Remote Sensing Bulletin. 27(8). 1821–1833.
3.
4.
Wang, Zhao, Yaqiong Liu, Xiao‐Bo Liao, & Shui‐Ping Zhao. (2020). The Role of Overexpressed Apolipoprotein AV in Insulin‐Resistant Hepatocytes. BioMed Research International. 2020(1). 3268505–3268505. 2 indexed citations
5.
Xu, Jin, Yanqiao Chen, Shui‐Ping Zhao, & Ling Liu. (2019). Determination of optimal cut-off points after a high-fat meal corresponding to fasting elevations of triglyceride and remnant cholesterol in Chinese subjects. Lipids in Health and Disease. 18(1). 206–206. 15 indexed citations
6.
7.
Fan, Liang‐Liang, Minjie Lin, Yaqin Chen, et al.. (2015). Novel Mutations of Low-Density Lipoprotein Receptor Gene in China Patients with Familial Hypercholesterolemia. Applied Biochemistry and Biotechnology. 176(1). 101–109. 9 indexed citations
8.
Tian, Yang, et al.. (2013). The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. Lipids in Health and Disease. 12(1). 151–151. 43 indexed citations
9.
10.
Zhao, Shui‐Ping, et al.. (2010). Effect of high-density lipoprotein on interleukin-8 secretion in 3T3-L1 adipocytes. Zhonghua neifenmi daixie zazhi. 26(10). 888–890. 2 indexed citations
11.
Xing, Yu, Shui‐Ping Zhao, & Rong Xiang. (2009). Alzheimer’s disease and atherosclerosis: Passers-by or brothers?. Medical Hypotheses. 73(2). 138–139. 1 indexed citations
12.
Zhao, Shui‐Ping, et al.. (2009). Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up‐regulating peroxisome proliferator‐activated receptor‐α. British Journal of Pharmacology. 158(3). 706–712. 34 indexed citations
13.
Zhao, Shui‐Ping, et al.. (2009). Study of CO2 supercritical technology on osthole extraction from common cnidium fruit.. 4(1). 20–22. 1 indexed citations
14.
Li, Xiangping, et al.. (2008). Relationship between apolipoprotein A5-1131T>C polymorphism and strokes. Chinese Journal of Neuromedicine. 7(9). 928–931. 1 indexed citations
15.
Zhao, Shui‐Ping. (2008). Key points of the Guidelines on Prevention and Treatment of Blood Lipid Abnormality in Chinese Adults. 1 indexed citations
16.
Zhao, Shui‐Ping. (2006). Anti-inflammatory Effects of Xuezhikang Capsule(血脂康胶囊). Chinese Journal of Integrative Medicine. 1 indexed citations
17.
Liu, Ling, et al.. (2004). Optimal time point to measure postprandial hypertriglyceridemia after a high-fat meal. Zhonghua neifenmi daixie zazhi. 20(1). 23–25. 4 indexed citations
18.
Zhao, Shui‐Ping. (2004). The Clinical Analysis of Anxiety Depression in Cardiovascular Patients. 1 indexed citations
19.
Liu, Ling, et al.. (2003). Influence of apolipoprotein E polymorphism on postprandial triglyceride metabolism in patients with coronary heart disease. 31(7). 505–508. 1 indexed citations
20.
Zhao, Shui‐Ping, et al.. (2002). [Correlation between blood pressure variability and left ventricular hypertrophy in patients with primary hypertension].. PubMed. 27(3). 253–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria-Corina Șerban Breakdown of academic impact, for papers by Jean Bergeron Breakdown of academic impact, for papers by Junji Kobayashi Breakdown of academic impact, for papers by Olivier Descamps Breakdown of academic impact, for papers by Kjetil Retterstøl Breakdown of academic impact, for papers by Gen Yoshino Breakdown of academic impact, for papers by Patrick M. Moriarty Breakdown of academic impact, for papers by P. Barton Duell Breakdown of academic impact, for papers by John R. Burnett Breakdown of academic impact, for papers by Mary J. Malloy
Rankless by CCL
2026